(Q39851823)

15 September 2017

title

Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation (English)

1 reference

15 September 2017

Jean-Michel Aubry

1

1 reference

15 September 2017

Michèle Schwald

series ordinal

2

1 reference

15 September 2017

Eladia Ballmann

series ordinal

3

1 reference

15 September 2017

Félicien Karege

series ordinal

4

1 reference

15 September 2017

publication date

14 May 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

205

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

419-429

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-009-1551-2

15 September 2017

exact match

0 references

cites work

Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1551-2

Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1551-2

Persistence of haloperidol in human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1551-2

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1551-2

Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1551-2

Olanzapine Serum Concentrations in Psychiatric Patients Given Standard Doses: The Influence of Comedication

21 January 2018

1 reference

12 December 2020

Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

1 reference

12 December 2020

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium

1 reference

12 December 2020

PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?

1 reference

12 December 2020

Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder

1 reference

12 December 2020

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

1 reference

12 December 2020

Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro

1 reference

12 December 2020

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

1 reference

12 December 2020

The effects of clozapine on the GSK-3-mediated signaling pathway

1 reference

12 December 2020

A molecular mechanism for the effect of lithium on development

1 reference

12 December 2020

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers

1 reference

12 December 2020

Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex

1 reference

12 December 2020

The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders

1 reference

12 December 2020

Olanzapine concentrations in clinical serum and postmortem blood specimens--when does therapeutic become toxic?

1 reference

12 December 2020

Mood stabilizers, glycogen synthase kinase-3beta and cell survival

1 reference

12 December 2020

The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials

1 reference

12 December 2020

A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency

1 reference

12 December 2020

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

1 reference

12 December 2020

Atypical antipsychotics in bipolar depression: potential mechanisms of action.

1 reference

12 December 2020

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

1 reference

12 December 2020

Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims.

1 reference

12 December 2020

A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation

1 reference

12 December 2020

Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells

1 reference

12 December 2020

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

1 reference

12 December 2020

Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells

1 reference

12 December 2020

Neuroimaging studies of mood disorder effects on the brain

1 reference

12 December 2020

Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38.

1 reference

12 December 2020

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

1 reference

12 December 2020

Protein kinase B (PKB/Akt)--a key regulator of glucose transport?

1 reference

12 December 2020

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

12 December 2020

Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder.

1 reference

12 December 2020

Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons

1 reference

12 December 2020

Atypical antipsychotics and mood stabilization in bipolar disorder

1 reference

12 December 2020

Lithium-induced increase in human brain grey matter

1 reference

12 December 2020

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

1 reference

12 December 2020

Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain

1 reference

12 December 2020

Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway

1 reference

12 December 2020

Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.

1 reference

12 December 2020

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain

1 reference

12 December 2020

Clozapine for Treatment-Refractory Schizophrenia, Schizoaffective Disorder, and Psychotic Bipolar Disorder

1 reference

12 December 2020

The glamour and gloom of glycogen synthase kinase-3

1 reference

12 December 2020

Neuronal glucose metabolism and schizophrenia: therapeutic prospects?

1 reference

12 December 2020

Lithium and valproic acid: parallels and contrasts in diverse signaling contexts

1 reference

12 December 2020

Akt/GSK3 signaling in the action of psychotropic drugs

1 reference

12 December 2020

GSK-3beta gene expression in human postmortem brain: regional distribution, effects of age and suicide.

1 reference

12 December 2020

Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics

1 reference

12 December 2020

Dosing strategies and time course of response to antimanic drugs

1 reference

12 December 2020

Antipsychotics in bipolar disorder

1 reference

12 December 2020

Lithium and brain signal transduction systems

1 reference

12 December 2020

10.1007/S00213-009-1551-2

Identifiers

DOI

1 reference

15 September 2017

1 reference